Delineate

Delineate develops AI agents focused on designing more efficient clinical trials. By processing existing clinical trial research into specialized datasets, Delineate saves scientists months of effort, significantly accelerating the trial process. Operating in a $10 billion market, even a single day saved can translate to $1-5 million in revenue potential. Delineate collaborates with two of the largest pharmaceutical companies, assisting one in advancing to the next trial phase more quickly by constructing the largest dataset ever created for a specific drug class.